Add Yahoo as a preferred source to see more of our stories on Google. Air Purifiers for asthma Almost 28 million people in the U.S. suffer from asthma, according to Kenneth Mendez, president and CEO ...

Dupilumab significantly outperformed omalizumab in reducing the size of nasal polyps and improving sense of smell in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting ...

Allergies and asthma affect millions in the US, with significant economic costs, especially for food allergies and asthma treatments. Insurance coverage disparities limit access to allergy and asthma ...

After breaking through the blockbuster sales threshold in 2025, AstraZeneca’s three-in-one inhaler Breztri Aerosphere has ...

New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases. Current asthma treatments don't work in all patients, and they ...

Dupilumab reduced airway inflammation and mucus burden and enhanced airway volume and flow, which led to better lung function and improved asthma control in patients with moderate to severe type 2 ...

Please provide your email address to receive an email when new articles are posted on . Depemokimab’s mechanism of action is similar to mepolizumab. Three adverse events led to discontinuation or ...

Let’s Kick Asthma: 6th Annual Benefit Gala is happening Saturday, August 16, 2025 at the Rosen Centre Hotel in Orlando, FL. Join us for an inspiring night dedicated to raising awareness, building ...

Asthma is one of the most common lung diseases in the world, affecting some 262 million people worldwide and causing more than 450,000 deaths annually, per the World Health Organization. While ...

Feng is an allergist/immunologist. Palaniappan is professor of medicine at Stanford University School of Medicine. Arroyo is clinical associate professor of medicine at Stanford University School of ...